Login / Signup

COVID-19 vaccines and their underbelly: Are we going the right way?

Bhabani Sankar SatapathyGurudutta PattnaikRudra Narayan SahooSovan PattanaikAshish K SarangiVenkataramana KandiSnehasish MishraAli A RabaanAroop MohantyRanjit SahRanjan K Mohapatra
Published in: Health science reports (2023)
Reliable data particularly on the safety of children is lacking as majority of the current over-the-counter COVID-19 vaccines were for emergency use. Many of these were still in their Phase III and Phase IV trials. The need for a mutant-proof, next-gen COVID-19 vaccine in the face of vaccine-associated adverse events is opined.
Keyphrases
  • coronavirus disease
  • sars cov
  • phase iii
  • clinical trial
  • emergency department
  • public health
  • young adults
  • respiratory syndrome coronavirus
  • healthcare
  • big data
  • randomized controlled trial
  • machine learning